Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Stomach Neoplasms × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 12 Breast Neoplasms 12 Neoplasms 9 Carcinoma, Squamous Cell 8 Head and Neck Neoplasms 7 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Glioblastoma 6 Colorectal Neoplasms 6 Recurrence 5 Melanoma 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Lymphoma, Non-Hodgkin 4 Lung Neoplasms 4 Leukemia, Myeloid, Acute 4 Lymphoma, Follicular 3 Leukemia 3 Fallopian Tube Neoplasms 3 Colonic Neoplasms 3 Brain Neoplasms 3 Treatment 2 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Mouth Neoplasms 2 Mesothelioma, Malignant 2 Lymphoma 2

Interventions

Oxaliplatin 46 Fluorouracil 41 Cisplatin 41 Capecitabine 38 Leucovorin 28 pembrolizumab 26 Docetaxel 20 Irinotecan 19 Paclitaxel 18 Trastuzumab 16 Bevacizumab 12 Ramucirumab 10 Cetuximab 9 Surgical Procedures, Operative 7 Radiotherapy 7 Nivolumab 7 S 1 (combination) 6 Epirubicin 6 Carboplatin 6 Sunitinib 4 Platinum 4 Mitomycin 4 trastuzumab deruxtecan 3 olaparib 3 bemarituzumab 3 Pemetrexed 3 Ipilimumab 3 Folfox protocol 3 Everolimus 3 zolbetuximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04082364 2025-06-08

MAHOGANY

MacroGenics

Phase 2/3 Completed

82 enrolled 22 charts

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡